Freya Biosciences License ApS
CVR 41372079 · Private limited company (ApS) · Active · Low risk
Freya Biosciences License ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 6 annual reports have been published, of which 4 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 357k and a net result of DKK -14k.
Bankruptcy risk for Freya Biosciences License ApS
0.4 × the average (1.41%) · higher risk than 66% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 41372079
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (6 years)
- Address
- Fruebjergvej 3
2100 København Ø - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 288k
- Auditor
- (venstre underskriver)
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 5 of 6 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 74.5% |
| Current ratio | 393% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 611 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -14k | DKK -30k | DKK -24k |
| Net profit | DKK -14k | DKK -30k | DKK -24k |
| Equity | DKK 357k | DKK 316k | DKK 195k |
| Total assets | DKK 479k | DKK 437k | DKK 257k |
| Cash | DKK 479k | DKK 437k | – |
| Short-term debt | DKK 122k | DKK 122k | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · (venstre underskriver).
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 183 | ||
| 1 Jan 2024 – 31 Dec 2024 | 188 | Late | |
| 1 Jan 2023 – 31 Dec 2023 | 177 | ||
| 1 Jan 2022 – 31 Dec 2022 | 184 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 301 | Late | |
| 19 May 2020 – 31 Dec 2020 | 196 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | Peter Finsel Bisgaard | Current | |
| Board | Henrijette Elsebeth Richter | Current | |
| Board | Colleen Denise Acosta | Current | |
| Board | Mark Smith | Current | |
| Board | Nicholas Haft | Current | |
| Board | Claudia Maria Colciago | Current | |
| Board | David Lawrence Stern | Current | |
| Board | Peter Finsel Bisgaard | ||
| Board | Thomas Gundelund Rasmussen | ||
| Board | Johannes Epeüs Theodoor van Hylckama Vlieg | ||
| Board | Henrijette Elsebeth Richter | ||
| Board | Colleen Denise Acosta | ||
| Board | Mark Smith | ||
| Board | Nicholas Haft | ||
| Owner (20%) | Sofinnova Capital X | Current | |
| Owner (5%) | OMX Opportunity Fund I, LLC | Current | |
| Owner (10%) | Danmarks Eksport- og Investeringsfond | Current | |
| Owner (5%) | OMX Ventures Fund I, LLC | Current | |
| Owner (5%) | Sofinnova Capital IX | Current | |
| Owner (15%) | Bill & Melinda Gates Foundation | Current | |
| Owner (20%) | Peter Finsel Bisgaard | ||
| Owner (20%) | Origem Holding ApS | ||
| Owner (5%) | ABT Consult ApS | ||
| Owner (20%) | Curanthia Holdings ApS | ||
| Owner (5%) | R. Rich Holding ApS | ||
| Owner (20%) | MBFH Consulting SAS | ||
| Owner (10%) | Peter Finsel Bisgaard | ||
| Owner (10%) | Origem Holding ApS | ||
| Owner (10%) | Curanthia Holdings ApS | ||
| Owner (10%) | MBFH Consulting SAS | ||
| Owner (10%) | OMX Ventures Fund I, LLC | ||
| Owner (10%) | Sofinnova Capital IX | ||
| Owner (20%) | OMX Ventures Fund I, LLC | ||
| Owner (20%) | Sofinnova Capital IX | ||
| Owner (5%) | Peter Finsel Bisgaard | ||
| Owner (10%) | VÆKSTFONDEN | ||
| Owner (5%) | Origem Holding ApS | ||
| Owner (5%) | Curanthia Holdings ApS | ||
| Owner (5%) | MBFH Consulting SAS | ||
| Owner (15%) | OMX Ventures Fund I, LLC | ||
| Owner (15%) | Sofinnova Capital IX | ||
| Owner (10%) | Danmarks Eksport- og Investeringsfond | ||
| Owner (10%) | OMX Ventures Fund I, LLC | ||
| Owner (10%) | Sofinnova Capital IX | ||
| Owner (5%) | Danmarks Eksport- og Investeringsfond | ||
| Owner (10%) | Bill & Melinda Gates Foundation | ||
| Founder | Peter Finsel Bisgaard | Current | |
| Founder | Origem Holding ApS | Current | |
| Founder | ABT Consult ApS | Current | |
| Founder | Curanthia Holdings ApS | Current | |
| Founder | R. Rich Holding ApS | Current | |
| Founder | MBFH Consulting SAS | Current | |
| Founder | Laura Marie Ensign-Hodges | Current | |
| Founder | Ulrich Klaus Binné | Current |
Address history (1 moves)
| Fruebjergvej 3, 2100 København Ø | |
| c/o Gorrissen Federspiel, Axeltorv 2, 1609 København V |
Other companies at the same address
- A DIMENSION GROUP A/S Bankrupt
- A-SYNTESE BIOTECH ApS Bankrupt
- ABSTRACTION ApS Bankrupt
- ADURA ApS Bankrupt
- AFVIKLINGSSELSKABET AF 8.2.1999 A/S Bankrupt
- ALLEGENETICS DIAGNOSTICS LABORATORY ApS Bankrupt
- ANSARI GROUP S.M.B.A. Bankrupt
- AQUALIFE A/S Bankrupt
- AREA NETWORKS ApS Bankrupt
- ASD Group Denmark ApS Bankrupt
- Afsluttet Projektselskab BLN ApS Bankrupt
- Andersen & Andersen IVS Bankrupt
- Andersentraveller ApS Bankrupt
- ApS VICTORIA STREET KOMPLEMENTAR Bankrupt
- Autocycle International ApS Bankrupt
- BB Ejendomme 2015 IVS Bankrupt
- BB Jyllands investering IVS Bankrupt
- BB Jyllands projekt IVS Bankrupt
- BINCORE GROUP A/S Bankrupt
- BINCORE INDUSTRIES A/S Bankrupt
- BLUSENSE DIAGNOSTICS APS Bankrupt
- BRUUNS INVEST ApS Bankrupt
- BRUUNS REVISION ApS Bankrupt
- BUILD ApS Bankrupt
- Baunsgaard Technologies ApS Bankrupt
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about Freya Biosciences License ApS
Has Freya Biosciences License ApS gone bankrupt?
No, Freya Biosciences License ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Freya Biosciences License ApS?
Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the auditor of Freya Biosciences License ApS?
Freya Biosciences License ApS most recently used (venstre underskriver).
When was Freya Biosciences License ApS founded?
Freya Biosciences License ApS was founded on 19 May 2020.
What is the equity of Freya Biosciences License ApS?
Equity was DKK 357k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.